Le Lézard
Classified in: Health

CenterWatch Announces -- Developing Pharmaceutical Investigational Brochures & Annual Reports: Secrets to Practical Success and Total Compliance Webinar, Jan. 29, 2019


FALLS CHURCH, Va., January 18, 2019 /PRNewswire-PRWeb/ -- Developing Pharmaceutical Investigational Brochures & Annual Reports:
Secrets to Practical Success and Total Compliance
**A CenterWatch Webinar**
Tuesday, Jan. 29, 2019, 1:30 p.m. - 3:00 p.m. ET
https://store.centerwatch.com/p-543-developing-pharmaceutical-investigational-brochures-annual-reports-secrets-to-practical-success-and-total-compliance.aspx

Are accurate data, frequency, methods of administration and safety monitoring procedures included in the IB's?

Do the IB's provide investigators with a clear-cut understanding of the possible risks and adverse reactions, and of the specific tests, observations, and precautions that may be needed for a clinical trial to prevent patient litigation?

Is the IB updated with the latest information on trials in a timely manner to comply with IRB guidelines? Remember, it's the responsibility of the sponsor to keep the information in the IB up to date, including when the drug has received marketing approval and can be prescribed for use commercially.

In the annual report, is the complete description of any significant Phase 1 protocol modifications made during the previous year and not previously reported to the IND in a protocol amendment provided?

Tiffany Guckin, associate director of regulatory affairs, Invicro, will discuss the importance of both FDA IND annual reports and investigator brochures and the benefits of timely submissions and reviews as well as the content and structure. Over the course of 90-minutes she'll help attendees understand:

This presentation will highlight appropriate content to be included in annual reports and investigational brochures.

Meet Your Presenter
Tiffany Guckin, MS is the associate director of regulatory affairs; Invicro, a Konica Minolta company. She is a graduate from the University of Connecticut and Quinnipiac University. Tiffany is an experienced regulatory professional with more than 8 years in leading all regulatory operation aspects of IND filings and maintenance, as well as authoring Investigational Brochures (IBs) for early phase imaging research studies.    

Who Will Benefit

Webinar Details:
Developing Pharmaceutical Investigational Brochures & Annual Reports:
Secrets to Practical Success and Total Compliance
**A CenterWatch Webinar**
Tuesday, Jan. 29, 2019, 1:30 p.m. - 3:00 p.m. ET
https://store.centerwatch.com/p-543-developing-pharmaceutical-investigational-brochures-annual-reports-secrets-to-practical-success-and-total-compliance.aspx

Tuition:
$287 per site

Easy Ways to Register:
Online: https://store.centerwatch.com/p-543-developing-pharmaceutical-investigational-brochures-annual-reports-secrets-to-practical-success-and-total-compliance.aspx
By phone: 866-219-3440

About CenterWatch:
Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.

SOURCE CenterWatch


These press releases may also interest you

at 11:29
In recognition of record-high levels of inequality, CareCentrix, among a coalition of 34 leading international companies, has committed to step up business action to advance human rights throughout their value chains, build inclusive workplaces and...

at 11:00
According to the new market research report "Enteral Feeding Devices Market by Type (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), Age Group (Adult, Pediatric), Application (Oncology, Diabetes, Hypermetabolism), End User (Hospital, Home...

at 11:00
The "Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering. The global allergy immunotherapies market was worth US$ 1.6 Billion in...

at 10:45
The "General and Pelvic Endoscopic Surgery Devices" report has been added to ResearchAndMarkets.com's offering. This report provides an in-depth analysis of the global market for medical devices used in endoscopic general and pelvic surgeries....

at 10:37
ESSA Pharma Inc. ("ESSA" or the "Company"), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce a public offering of equity securities of the Company in Canada and a concurrent...

at 10:36
Rosemarie Corrigan has today, 23 August, purchased 2,436 shares in Nordic Nanovector ASA (the "Company") at an average share price of NOK 24.56 per share. Following this transaction, Rosemarie Corrigan owns 2,436 shares in the Company and holds...



News published on 18 january 2019 at 00:00 and distributed by: